← Leaderboards
Michael Fetell
Columbia University Health Sciences
$385,820
Attributed
$385,820
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$385,820 · 1
By mechanism
M01$385,820 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Cory Abate-Shen$42,493,197
- Elisa E Konofagou$45,415,693
- Sohail F. Tavazoie$17,223,453
- Anil K Rustgi$51,275,906
- Wei Zheng$7,129,788
Others in their field
Top investigators on “Blood Brain Barrier”
- Berislav V Zlokovic · University Of Rochester$46,148,415
- Michal J. Toborek · University Of Kentucky$31,822,434
- Edward A Neuwelt · Oregon Health And Science University$27,712,098
- Yuri Persidsky · Temple Univ Of The Commonwealth$26,469,363
- Joan Weinberger Berman · Yeshiva University$21,803,760
- Katerina Akassoglou · University Of California San Diego$19,086,450
Research focus
Blood Brain BarrierBrain NeoplasmsClinical ResearchClinical Trial Phase IDrug InteractionsDrug Screening /EvaluationHuman SubjectHuman Therapy EvaluationMetastasisNeoplasm /Cancer ChemotherapyNeuropharmacologyPaclitaxelTamoxifen
Grant awards (5)
CHEMOTHERAPY OF PRIMARY AND METASTATIC CNS NEOPLASM--CNS PENETRATION$192,910
M01 · FY2002 · RR
CHEMOTHERAPY OF PRIMARY AND METASTATIC CNS NEOPLASM--CNS PENETRATION$192,910
M01 · FY2001 · RR
CHEMOTHERAPY OF PRIMARY AND METASTATIC CNS NEOPLASM--CNS PENETRATION$0
M01 · FY2001 · RR
CHEMOTHERAPY OF PRIMARY AND METASTATIC CNS NEOPLASM--CNS PENETRATION$0
M01 · FY2000 · RR
CHEMOTHERAPY OF PRIMARY AND METASTATIC CNS NEOPLASM--CNS PENETRATION$0
M01 · FY2000 · RR